BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 8247550)

  • 21. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T; Li SF; Shiozawa T; Fujii S
    Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
    Geum D; Sun W; Paik SK; Lee CC; Kim K
    Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.
    Lukas J; Pagano M; Staskova Z; Draetta G; Bartek J
    Oncogene; 1994 Mar; 9(3):707-18. PubMed ID: 8108113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention.
    Weinstein IB
    J Cell Biochem Suppl; 1996; 25():23-8. PubMed ID: 9027594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of cyclin D1 in mouse skin carcinogenesis.
    Bianchi AB; Fischer SM; Robles AI; Rinchik EM; Conti CJ
    Oncogene; 1993 May; 8(5):1127-33. PubMed ID: 8479737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
    Lebwohl DE; Muise-Helmericks R; Sepp-Lorenzino L; Serve S; Timaul M; Bol R; Borgen P; Rosen N
    Oncogene; 1994 Jul; 9(7):1925-9. PubMed ID: 8208539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
    Yu Q; Ciemerych MA; Sicinski P
    Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth.
    Han EK; Sgambato A; Jiang W; Zhang YJ; Santella RM; Doki Y; Cacace AM; Schieren I; Weinstein IB
    Oncogene; 1995 Mar; 10(5):953-61. PubMed ID: 7898937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
    Lukas J; Jadayel D; Bartkova J; Nacheva E; Dyer MJ; Strauss M; Bartek J
    Oncogene; 1994 Aug; 9(8):2159-67. PubMed ID: 8036001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation.
    Marhin WW; Hei YJ; Chen S; Jiang Z; Gallie BL; Phillips RA; Penn LZ
    Oncogene; 1996 Jan; 12(1):43-52. PubMed ID: 8552398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells.
    Uto H; Ido A; Moriuchi A; Onaga Y; Nagata K; Onaga M; Tahara Y; Hori T; Hirono S; Hayashi K; Tsubouchi H
    Cancer Res; 2001 Jun; 61(12):4779-83. PubMed ID: 11406552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ; Li SA; Tawfik O; Li JJ
    Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.
    Nakagawa H; Wang TC; Zukerberg L; Odze R; Togawa K; May GH; Wilson J; Rustgi AK
    Oncogene; 1997 Mar; 14(10):1185-90. PubMed ID: 9121767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ; Dickson RB
    Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP; Tamimi Y; Schuuring E; Schalken J
    Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
    Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.
    Lukas J; Bartkova J; Welcker M; Petersen OW; Peters G; Strauss M; Bartek J
    Oncogene; 1995 Jun; 10(11):2125-34. PubMed ID: 7784057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells.
    Al Moustafa AE; Foulkes WD; Wong A; Jallal H; Batist G; Yu Q; Herlyn M; Sicinski P; Alaoui-Jamali MA
    Oncogene; 2004 Jul; 23(30):5252-6. PubMed ID: 15229656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle.
    Daksis JI; Lu RY; Facchini LM; Marhin WW; Penn LJ
    Oncogene; 1994 Dec; 9(12):3635-45. PubMed ID: 7526316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.